DK0540813T3 - Acetazolamid-præparat med vedvarende afgift af aktivt stof - Google Patents

Acetazolamid-præparat med vedvarende afgift af aktivt stof

Info

Publication number
DK0540813T3
DK0540813T3 DK92108329.1T DK92108329T DK0540813T3 DK 0540813 T3 DK0540813 T3 DK 0540813T3 DK 92108329 T DK92108329 T DK 92108329T DK 0540813 T3 DK0540813 T3 DK 0540813T3
Authority
DK
Denmark
Prior art keywords
acetazolamide
sustained
active ingredient
release active
release
Prior art date
Application number
DK92108329.1T
Other languages
Danish (da)
English (en)
Inventor
Nicholas Ian Payne
David Parker
Angela Catherine Potts
Laurence Charles Staines
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0540813T3 publication Critical patent/DK0540813T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92108329.1T 1991-06-11 1992-05-18 Acetazolamid-præparat med vedvarende afgift af aktivt stof DK0540813T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9112495A GB2256587A (en) 1991-06-11 1991-06-11 Acetazolamide in sustained release form

Publications (1)

Publication Number Publication Date
DK0540813T3 true DK0540813T3 (da) 1996-07-22

Family

ID=10696429

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92108329.1T DK0540813T3 (da) 1991-06-11 1992-05-18 Acetazolamid-præparat med vedvarende afgift af aktivt stof

Country Status (11)

Country Link
EP (1) EP0540813B1 (fi)
AT (1) ATE135568T1 (fi)
CA (1) CA2070877C (fi)
DE (1) DE69209228T2 (fi)
DK (1) DK0540813T3 (fi)
ES (1) ES2086576T3 (fi)
FI (1) FI101855B1 (fi)
GB (1) GB2256587A (fi)
GR (1) GR3019751T3 (fi)
NO (1) NO922282L (fi)
ZA (1) ZA924242B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
EP1615619A2 (en) 2003-04-23 2006-01-18 Ferring B.V. Sachet for a pharmaceutical composition
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
RU2009137946A (ru) 2007-03-15 2011-04-20 Шеринг Корпорейшн (US) Производные пиридазинона для применения в качестве ингибиторов глюкансинтазы
CN102949377B (zh) * 2012-11-28 2015-05-27 河南中帅医药科技股份有限公司 乙酰唑胺缓释胶囊及其制备方法
CN106822015A (zh) * 2017-03-27 2017-06-13 华益药业科技(安徽)有限公司 乙酰唑胺缓释片及其制备方法
CN113855648B (zh) * 2021-12-03 2022-02-25 北京联嘉医药科技开发有限公司 一种乙酰唑胺缓释胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3671633A (en) * 1971-05-10 1972-06-20 American Cyanamid Co Process for tabletting acetazolamide
US4305927A (en) * 1979-02-05 1981-12-15 Alza Corporation Method for the management of intraocular pressure
GB2135879B (en) * 1983-03-07 1986-05-21 Ciba Geigy Ag Pharmaceutical preparations with uniform elution properties
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form

Also Published As

Publication number Publication date
FI922698A (fi) 1992-12-12
CA2070877A1 (en) 1992-12-12
ZA924242B (en) 1993-03-31
GB2256587A (en) 1992-12-16
CA2070877C (en) 2003-02-11
NO922282D0 (no) 1992-06-10
GB9112495D0 (en) 1991-07-31
NO922282L (no) 1992-12-14
EP0540813B1 (en) 1996-03-20
FI922698A0 (fi) 1992-06-10
DE69209228D1 (de) 1996-04-25
GR3019751T3 (en) 1996-07-31
ES2086576T3 (es) 1996-07-01
FI101855B (fi) 1998-09-15
DE69209228T2 (de) 1996-11-21
ATE135568T1 (de) 1996-04-15
EP0540813A1 (en) 1993-05-12
FI101855B1 (fi) 1998-09-15

Similar Documents

Publication Publication Date Title
DK0591424T3 (da) Diltiazem-holdigt lægemiddel med forlænget frigivelse
SE9102072D0 (sv) Oral, fast, farmaceutisk doseringsform med styrd frisaettning
DE69435295D1 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
ATE235234T1 (de) Mesalazine enthaltende pharmazeutische zusammensetzungen mit gesteuerte freisetzung
OA09479A (fr) "Triazolopyridines herbicides".
DK0519820T3 (da) Matrixtablet, som muliggør længerevarende frigivelse af indapamid efter oral administration
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
DE59003337D1 (de) Pressling mit retardierter Wirkstofffreisetzung.
AU4694189A (en) 2-(4,6-dimethoxy-2-pyrimidinyloxy)benzaldoximes, preparation processes thereof, herbicides containing G the same, and herbicidal compositions containing the same along with other active ingredient
UA19307A (uk) Гербіцидhий засіб
DK0540813T3 (da) Acetazolamid-præparat med vedvarende afgift af aktivt stof
DK0947196T3 (da) Fremstilling med langvarig frigivelse af et prostaglandin I-derivat
IT1213420B (it) "n(-2,6-difluorobenzoil)-n'-3-cloro -41,1,2-trifluoro-2-(trifluorometossi ) etossi fenil urea ad attivita'insetticida.
FR2661070B1 (fr) Compositions insecticides a base de chrysanthemate de 2,4-dioxo-1-(2-propynyl) imidazolidine-3-ylmethyle.
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
YU82693A (sh) Farmaceutske formulacije disulfonil metana i novi disulfonil metani
ES2038729T3 (es) Producto insecticida.
DE59008309D1 (de) Fungizide Wirkstoffkombinationen.
DE59002649D1 (de) Fungizide Wirkstoffkombinationen.
EP0547224A4 (fi)
DK113388D0 (da) Laegemiddel med forsinket afgivelse af virksomt stof
FR2696345B3 (fr) Composition cosmétique à ingrédient actif enrobé.
ATE81002T1 (de) Fixe arzneimittelkombination mit verzoegerter freisetzung.
SV1988000015A (es) Procedimiento para preparar pirazolinas, ref. p-sal-44,240.